There is a “real possibility” that the Johnson & Johnson vaccines ready to be distributed to South Africans from the Gqebherha plant will not be suitable for use.

This is according to the health ministry, commenting on Friday night after the US Food and Drug Administration (FDA) confirmed that just two batches of the vaccine from a Baltimore laboratory were being released, while others were not. The number of vaccines per batch was not specified in the FDA statement...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.